GQG Partners’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.57M | Buy |
62,535
+59,079
| +1,709% | +$7.15M | 0.01% | 67 |
|
|
2025
Q1 | $385K | Hold |
3,456
| – | – | ﹤0.01% | 78 |
|
|
2024
Q4 | $336K | Sell |
3,456
-222
| -6% | -$21.6K | ﹤0.01% | 91 |
|
|
2024
Q3 | $423K | Buy |
3,678
+1,203
| +49% | +$138K | ﹤0.01% | 75 |
|
|
2024
Q2 | $263K | Buy |
+2,475
| New | +$263K | ﹤0.01% | 75 |
|
|
2023
Q1 | – | Sell |
-2,446
| Closed | -$222K | – | 89 |
|
|
2022
Q4 | $222K | Sell |
2,446
-13,214
| -84% | -$1.2M | ﹤0.01% | 83 |
|
|
2022
Q3 | $1.19M | Hold |
15,660
| – | – | ﹤0.01% | 78 |
|
|
2022
Q2 | $1.32M | Buy |
15,660
+1,278
| +9% | +$108K | ﹤0.01% | 67 |
|
|
2022
Q1 | $1.26M | Buy |
14,382
+1,168
| +9% | +$102K | ﹤0.01% | 63 |
|
|
2021
Q4 | $1.16M | Sell |
13,214
-2,752
| -17% | -$241K | ﹤0.01% | 71 |
|
|
2021
Q3 | $1.31M | Hold |
15,966
| – | – | ﹤0.01% | 55 |
|
|
2021
Q2 | $1.46M | Hold |
15,966
| – | – | ﹤0.01% | 51 |
|
|
2021
Q1 | $1.37M | Buy |
15,966
+2,752
| +21% | +$235K | 0.01% | 52 |
|
|
2020
Q4 | $1.25M | Buy |
+13,214
| New | +$1.25M | ﹤0.01% | 52 |
|
|
2020
Q1 | – | Sell |
-4,442
| Closed | -$421K | – | 69 |
|
|
2019
Q4 | $421K | Buy |
+4,442
| New | +$421K | ﹤0.01% | 48 |
|
|
2019
Q1 | – | Sell |
-5,108
| Closed | -$393K | – | 48 |
|
|
2018
Q4 | $393K | Sell |
5,108
-1,874
| -27% | -$144K | 0.01% | 43 |
|
|
2018
Q3 | $539K | Hold |
6,982
| – | – | 0.01% | 44 |
|
|
2018
Q2 | $473K | Buy |
+6,982
| New | +$473K | 0.01% | 43 |
|
|
2018
Q1 | – | Sell |
-3,393
| Closed | -$255K | – | 60 |
|
|
2017
Q4 | $255K | Hold |
3,393
| – | – | 0.01% | 52 |
|
|
2017
Q3 | $261K | Sell |
3,393
-1,517
| -31% | -$117K | 0.01% | 55 |
|
|
2017
Q2 | $367K | Buy |
+4,910
| New | +$367K | 0.03% | 48 |
|